Azione 9776 SAPPORO CLINICAL LABORATORY INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Sapporo Clinical Laboratory Inc.

Azioni

9776

JP3321100004

Tempo differito Japan Exchange
Altri mercati azionari
 03:11:47 18/07/2024 		Variaz. 5gg Var. 1 gen.
1.012 JPY +0,40% Grafico intraday di Sapporo Clinical Laboratory Inc. +0,30% +1,10%
26/02 Sapporo Clinical Laboratory Inc. (TSE:9776) annuncia un riacquisto di azioni per 232.100 azioni, pari al 6,97% per 209,12 milioni di yen. CI
26/02 Sapporo Clinical Laboratory Inc. autorizza un piano di riacquisto. CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!
Registrazione 100% gratuita
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 232,100 shares, representing 6.97% for ¥209.12 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Sapporo Clinical Laboratory Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on May 30, 2022 has closed with 22,700 shares, representing 0.67% for ¥29.21 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 22,700 shares, representing 0.68% for ¥29.21 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 28, 2022.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 28, 2022, has closed with 53,700 shares, representing 1.58% for ¥69.11 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 53,700 shares, representing 1.58% for ¥69.11 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 21, 2021.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 21, 2021, has closed with 16,300 shares, representing 0.48% for ¥25.92 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 16,300 shares, representing 0.48% for ¥25.92 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 26, 2018.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 26, 2018 has expired with 39,200 shares, representing 1.13% for ¥96 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 45,000 shares, representing 1.3% for ¥110.21 million.
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 9776
  4. Notizie Sapporo Clinical Laboratory Inc.
  5. Altre lingue